---
schema_version: "secwatch.filing_event.v1"
accession: "0000064803-26-000009"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2026-02-10T23:59:59+00:00"
generated_at: "2026-05-16T03:43:42.466033+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# CVS Health Q4 revenue $105.7B (+8.2%); adj. EPS $1.09 vs $1.19; 2026 adj. EPS guide $7.00-$7.20

## Summary
- Full-year 2025 revenue record $402.1B (+7.8%); GAAP EPS $1.39 (incl. $5.7B goodwill impairment), Adj. EPS $6.75 (+24.5%).
- Q4 Health Care Benefits segment adj. op. loss ($676M) widened from ($439M) on IRA Medicare Part D seasonality.
- Pharmacy & Consumer Wellness Q4 adj. op. income $1,911M (+8.7%) on higher prescription volume including Rite Aid acquisitions.
- 2026 guidance: GAAP EPS $5.94-$6.14; Adj. EPS $7.00-$7.20; cash flow from operations at least $9.0B (down from prior $10.0B).
- Medical membership 26.6M, down 0.5M YoY; days claims payable 38.9 (down 3.6 days from Q3).

## SEC filing metadata
- accession: 0000064803-26-000009
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2026-02-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000006480326000009/0000064803-26-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000006480326000009/cvs-20260210.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000064803-26-000009
- JSON: https://secwatch.observer/filing/0000064803-26-000009.json
- Plain text: https://secwatch.observer/filing/0000064803-26-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.